Clinical Trials

Showing trials with last updates posted in 2023.

NCT03823885 | COMPLETED | NA
148 participants

ECigs, Inflammation and Oxidative Stress

Study Type:
INTERVENTIONAL
Last Updated:
2023-10-04
Start Date:
2019-02-08
Completion:
2023-02-08
Conditions
  • E-cigarettes, Oxidative Stress, Inflammation
Interventions
  • OTHER
No Results Yet
NCT03292510 | COMPLETED | NA
190 participants

Getting Older Adults OUTdoors (GO-OUT)

Study Type:
INTERVENTIONAL
Last Updated:
2023-10-04
Start Date:
2018-02-26
Completion:
2020-08-31
Conditions
  • Older Adults With Decreased Outdoor Walking Ability
Interventions
  • OTHER
No Results Yet
NCT02649764 | COMPLETED | PHASE1
15 participants

Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2023-10-04
Start Date:
2016-05-04
Completion:
2022-07-12
Conditions
  • Chronic Myelomonocytic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Recurrent High Risk Myelodysplastic Syndrome
  • Refractory Acute Myeloid Leukemia
  • Refractory High Risk Myelodysplastic Syndrome
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02276937 | ACTIVE_NOT_RECRUITING | PHASE2
30 participants

Randomized Phase IIb Trial of DVC1-0101

Study Type:
INTERVENTIONAL
Last Updated:
2023-10-04
Start Date:
2014-10-31
Completion:
2021-12-31
Conditions
  • Intermittent Claudication
  • Peripheral Arterial Disease
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page